An empirical study of alcohol consumption by patients considering HCV treatment

American Journal of Drug and Alcohol Abuse

Volumn 40, Issue 6, 2014, Pages 484-489

  North, Carol S ^a   Sims, Omar ^b   Hong, Barry A ^c   Jain, Mamta K ^a   Brown, Geri ^a   Lisker Melman, Mauricio ^c   Pollio, David E ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

Alcohol consumption patterns; Alcohol use disorder; Drug use; Hepatitis C; Liver damage

Indexed keywords

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ANTIVIRAL THERAPY; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; EMPIRICISM; FEMALE; GENDER; HEALTH SURVEY; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MENTAL DISEASE; SELF REPORT; SMOKING; URINALYSIS; ADVERSE EFFECTS; AGED; DRINKING BEHAVIOR; MIDDLE AGED; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SUBSTANCE-RELATED DISORDERS; TIME; YOUNG ADULT;

ANTIVIRUS AGENT;

ADULT; AGED; ALCOHOL DRINKING; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK-TAKING; SEX FACTORS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS; YOUNG ADULT;

EID: 84911912445     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.3109/00952990.2014.945592     Document Type: Article

References (22)

1. Ly KN, Xing J, Klevens RM, Jiles RB, Holmberg SD. Causes of death and characteristics of decedents with viral hepatitis, United States, 2010. Clin Infect Dis 2013;58:40-49.
2. Bruggmann P, Dampz M, Gerlach T, Kravecz L, Falcato L. Treatment outcome in relation to alcohol consumption during hepatitis C therapy: an analysis of the Swiss Hepatitis C Cohort Study. Drug Alc Dep 2010;110:167-171.
3. Szabo G, Aloman C, Polyak SJ, Weinman SA, Wands J, Zakhari S. Hepatitis C infection and alcohol use: a dangerous mix for the liver and antiviral immunity. Alc Clin Exp Res 2006;30:709-719.
4. Singal AK, Anand BS. Mechanisms of synergy between alcohol and hepatitis C virus. J Clin Gastroenterol 2007;41:761-772.
5. Younossi ZM, Zheng L, Stepanova M, Venkatesan C, Mir HM. Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C. Aliment Pharmacol Therapeut 2013;37: 703-709.
6. Anand BS, Thornby J. Alcohol has no effect on hepatitis C virus replication: a meta-analysis. Gut 2005;54:1468-1472.
7. McCartney EM, Beard MR. Impact of alcohol on hepatitis C virus replication and interferon signaling. World J Gastroenterol 2010;16: 1337-1343.
8. Hepatitis C Guidance Panel. Recommendations for testing, managing, and treating hepatitis C (revised 21 March 2014). American Association for the Study of Liver Diseases and Infectious Diseases Society of America 2014. Available from: http://www.hcvguidelines.org. [last accessed 21 June 2014].
9. Ghany MG, Strader DB, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 2009;49:1335-1374.
10. National Institutes of Health. Consensus development conference statement: management of hepatitis C: 10-12 June 2002. Hepatology 2002;36:S3-20.
11. North CS, Hong BA, Adewuyi SA, Pollio DE, Jain MK, Devereaux R, Quartey NA, et al. Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations. Gen Hosp Psychiat 2013;35:122-128.
12. Anand BS, Currie S, Dieperink E, Bini EJ, Shen H, Ho SB, Wright T. Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. Gastro 2006;130:1607-1616.
13. US Preventive Services Task Force. Screening for hepatitis C virus infection in adults: recommendation statement. Ann Intern Med 2004;140:462-464.
14. Perzynski AT, McCormick R, Webster NJ, Blixen CE, Kanuch S, Thomas CL, Mullen KD, Dawson NV. Psychosocial correlates of alcohol use and reduction for individuals with hepatitis C. J Stud Alcohol Drugs 2011;72:787-798.
15. Pollio DE, North CS, Hudson AM, Hong BA. A comparison of enrollees versus non-enrollees in a patient/family HCV psychoeducation study. J Clin Psychol Med Settings 2013;20:156-163.
16. Robins LN, Cottler LB, Compton WM, Bucholz K, North CS, Rourke KM. Diagnostic Interview Schedule for the DSM-IV (DISIV). St. Louis: Washington University; 2000.
17. World Health Organization (WHO). The Composite International Diagnostic Interview-Substance Abuse Module. Geneva: WHO; 2004.
18. Schilling RF, Bidassie B, El Bassel N. Detecting cocaine and opiates in urine: comparing three commercial assays. J Psychoact Drugs 1999;31:305-313.
19. Scognamiglio P, Galati V, Navarra A, Longo MA, Aloisi MS, Antonini MG, Puoti M, et al. Impact of hepatitis C virus infection on lifestyle. World J Gastroenterol 2007;13:2722-2726.
20. Stephens DB, Havens JR. Predictors of alcohol use among rural drug users after disclosure of hepatitis C virus status. J Stud Alcohol Drugs 2013;74:386-395.
21. Centers for Disease Control and Prevention. Alcohol use and health. Centers for Disease Control and Prevention 2013. Available from: http://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm [last accessed 9 December 2013].
22. National Institute on Alcohol Abuse and Alcoholism. Rethinking drinking. Alcohol and your health. US Department of Health and Human Services, National Institutes of Health 2013. Available from; http://rethinkingdrinking.niaaa.nih.gov/IsYourDrinking PatternRisky/WhatsLowRiskDrinking.asp [last accessed 9 December 2013].